NCT07174388unknownrecruiting

An External Control Arm Study in Non-Small Cell Lung Cancer

N-Power Medicine

ClinicalTrials.gov

650

Enrollment · estimated

Countries · 8 sites

2029-04

Primary completion

1 mo ago

Record updated

Commercial relevance

No explicit biomarker / molecular-testing language identified in the public record.

Biomarker requirement language

2. Pathologically confirmed locally advanced or metastatic NSCLC

Change timeline

No changes detected yet. The first refresh records a baseline snapshot; subsequent refreshes generate field-level changes.

Signals from this trial

New trial
32/100
Opportunity
New unknown trial NCT07174388 posted by N-Power Medicine: "An External Control Arm Study in Non-Small Cell Lung Cancer".
ClinicalTrials.gov record updated 29 days ago.

Eligibility — raw, for validation

Inclusion Criteria:

1. \> 18 years of age at the time of informed consent
2. Pathologically confirmed locally advanced or metastatic NSCLC
3. ECOG Performance of less than or equal to 1 within 4 weeks prior to starting index therapy.
4. Life expectancy of more than 3 months
5. Able to understand and sign informed consent
6. Evidence of measurable disease (as assessed by the Investigator) on available imaging (e.g CT, MRI, PET)

\*see protocol for cohort specific inclusion criteria\*

Exclusion Criteria:

1. Actively on a clinical trial of an investigational agent
2. Currently receiving active systemic therapy for another malignancy
3. Eligible for treatment with curative intent

\*see protocol for cohort specific exclusion criteria\*